Alignment Healthcare, Inc.
ALHC
$16.35
-$0.02-0.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 33.61% | 45.10% | 43.71% | 49.27% | 47.70% |
| Total Other Revenue | -2.90% | -4.68% | 26.17% | 26.32% | 26.17% |
| Total Revenue | 33.26% | 44.43% | 43.51% | 49.03% | 47.46% |
| Cost of Revenue | 32.87% | 44.85% | 41.50% | 45.67% | 43.21% |
| Gross Profit | 36.26% | 41.51% | 59.10% | 75.78% | 91.45% |
| SG&A Expenses | 16.79% | 24.30% | 21.07% | 18.04% | 14.56% |
| Depreciation & Amortization | 12.63% | 27.62% | 4.41% | 7.85% | 16.45% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.93% | 41.80% | 38.51% | 41.86% | 39.11% |
| Operating Income | 475.59% | 46.95% | 143.15% | 229.60% | 89.57% |
| Income Before Tax | 222.59% | 54.17% | 114.11% | 178.72% | 79.96% |
| Income Tax Expenses | 19.05% | -46,200.00% | 125.00% | 14,554.55% | -- |
| Earnings from Continuing Operations | 222.04% | 64.57% | 114.11% | 165.21% | 79.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 100.00% | -- | 300.00% | 344.44% |
| Net Income | 225.26% | 64.60% | 114.12% | 165.25% | 80.41% |
| EBIT | 475.59% | 46.95% | 143.15% | 229.60% | 89.57% |
| EBITDA | 769.46% | 78.22% | 242.46% | 365.15% | 107.89% |
| EPS Basic | 218.05% | 66.17% | 113.55% | 162.80% | 80.86% |
| Normalized Basic EPS | 243.65% | 45.64% | 115.80% | 179.40% | 83.44% |
| EPS Diluted | 200.00% | 65.74% | 113.36% | 153.85% | 79.68% |
| Normalized Diluted EPS | 238.49% | 45.64% | 115.09% | 175.13% | 83.44% |
| Average Basic Shares Outstanding | 6.07% | 4.73% | 4.01% | 3.90% | 2.43% |
| Average Diluted Shares Outstanding | 10.08% | 4.73% | 9.18% | 9.76% | 2.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |